TRACERx NSCLC - Whole exome multiregion sequencing data from the 421 cohort
TRACERx NSCLC - Whole exome multiregion sequencing data from the 421 cohort
- 2193 samples
- DAC: EGAC00001000632
- Technology: Illumina HiSeq 2000
TRACERx Non-small cell lung cancer
”The Francis Crick Institute allows access to published datasets upon written application and signature of a Data Access Agreement (DAA) to be provided. Applications require approval by the TRACERx Data Access Committee (DAC), who assess whether the proposed work is allowed given patient consent, as well as the scientific purpose. Requestors will be provided with a data access form upon contact with the TRACERx DAC.”
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Exome Sequencing |